Home › Acute Myeloid Leukemia › Massachusetts › Somerville
Acute Myeloid Leukemia clinical trials in Somerville, MA
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Somerville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Lahey Clinic, Burlington · 9 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Lahey Clinic, Burlington · 9 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Lahey Clinic, Burlington · 9 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA30 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Somerville
- Breast Cancer8 studies
- Non-Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Respiratory Distress Syndrome5 studies
- Acute Lung Injury4 studies
- Cancer (all types)3 studies
- Bladder Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Ischemic Stroke3 studies
- Autism3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.